CLRB
Cellectar Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.14
+0.00%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.56
- Revenue estimate
- $17.0M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.57
- EPS estimate
- -$0.52
- Revenue actual
- —
- Revenue estimate
- $12.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +25.4%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.52 | -$0.57 | Miss -9.62% | — |
| May 14, 2026 | -$1.89 | -$1.33 | Beat 29.44% | — |
| Mar 4, 2026 | -$1.19 | -$0.53 | Beat 55.46% | — |
| Nov 13, 2025 | -$1.91 | -$1.41 | Beat 26.18% | — |
| Aug 14, 2025 | -$3.60 | -$3.39 | Beat 5.83% | — |
| Mar 13, 2025 | -$0.38 | -$0.01 | Beat 97.37% | — |
| Aug 14, 2023 | -$0.69 | -$0.73 | Miss -5.80% | — |
| May 4, 2023 | -$0.75 | -$0.76 | Miss -1.33% | — |
| Mar 9, 2023 | -$0.83 | -$0.55 | Beat 33.73% | — |
| Nov 3, 2022 | -$1.21 | -$1.28 | Miss -5.79% | — |
| Aug 5, 2022 | -$1.08 | -$1.22 | Miss -12.96% | — |
| Mar 21, 2022 | -$1.00 | -$1.00 | In line | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026